» Articles » PMID: 12780684

Absence of CD4+CD25+ Regulatory T Cells is Associated with a Loss of Regulation Leading to Increased Pathology in Helicobacter Pylori-infected Mice

Overview
Date 2003 Jun 5
PMID 12780684
Citations 62
Authors
Affiliations
Soon will be listed here.
Abstract

Helicobacter pylori induces symptomatic chronic gastritis in a subpopulation of infected individuals. The mechanism(s) determining the development and severity of pathology leading to symptoms are not fully understood. In a mouse model of H. pylori infection we analysed the influence of immunoregulatory CD4+CD25+ T cells on H. pylori colonization and gastritis. Athymic C57BL/6 nu/nu mice were reconstituted with (a) lymph node (LN) cells (b) LN cells depleted of CD25+ T cells (CD25(-) LN) or (c) not reconstituted at all. Mice were then infected orally with 3 x 10(8)H. pylori SS1 bacteria. At 2 and 6 weeks after the inoculation there was a significant (P < 0.001) reduction in H. pylori colonization in athymic mice transferred with CD25(-) LN cells compared to mice transferred with LN cells. Colonization was still reduced at 12 weeks after inoculation. Mice transferred with CD25(-) LN cells showed an earlier onset and increased severity of gastritis as compared to mice receiving LN cells. Splenic cells isolated from mice receiving CD25(-) LN cells produced the highest level of IFN-gamma on stimulation with H. pylori antigens in vitro, had a higher H. pylori-specific DTH response and increased infiltration of CD4+ T cells and macrophages in the gastric mucosa. Athymic mice not transferred with T cells had persistent high H. pylori colonization and displayed a normal gastric epithelium without inflammatory cells. In conclusion, CD4+CD25+ cells reduce immunopathology in H. pylori infection, possibly by reducing the activation of IFN-gamma producing CD4+ T cells, even at the expense of a higher H. pylori load in the gastric mucosa.

Citing Articles

Strategies of in evading host innate and adaptive immunity: insights and prospects for therapeutic targeting.

Fan J, Zhu J, Xu H Front Cell Infect Microbiol. 2024; 14:1342913.

PMID: 38469348 PMC: 10925771. DOI: 10.3389/fcimb.2024.1342913.


Antibacterial and Immunoregulatory Effects of Metformin against Infection in Rat Model.

Valadbeigi H, Khoshnood S, Negahdari B, Abdullah M, Haddadi M Biomed Res Int. 2024; 2023:5583286.

PMID: 38192437 PMC: 10774005. DOI: 10.1155/2023/5583286.


Immune Response in Children Versus Adults.

Reyes V Med Res Arch. 2023; 10(12).

PMID: 37936946 PMC: 10629867. DOI: 10.18103/mra.v10i12.3370.


Genetics of Host Protection against Infections.

Capparelli R, Iannelli D Int J Mol Sci. 2021; 22(6).

PMID: 33801073 PMC: 8004045. DOI: 10.3390/ijms22063192.


T Cell Cytokines Impact Epithelial Cell Responses during Infection.

Algood H J Immunol. 2020; 204(6):1421-1428.

PMID: 32152211 PMC: 7080313. DOI: 10.4049/jimmunol.1901307.


References
1.
Pappo J, Torrey D, Castriotta L, Savinainen A, Kabok Z, Ibraghimov A . Helicobacter pylori infection in immunized mice lacking major histocompatibility complex class I and class II functions. Infect Immun. 1998; 67(1):337-41. PMC: 96315. DOI: 10.1128/IAI.67.1.337-341.1999. View

2.
Ermak T, Giannasca P, Nichols R, Myers G, Nedrud J, Weltzin R . Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses. J Exp Med. 1998; 188(12):2277-88. PMC: 2212427. DOI: 10.1084/jem.188.12.2277. View

3.
Thornton A, Shevach E . Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific. J Immunol. 1999; 164(1):183-90. DOI: 10.4049/jimmunol.164.1.183. View

4.
Sutton P, Wilson J, Lee A . Further development of the Helicobacter pylori mouse vaccination model. Vaccine. 2000; 18(24):2677-85. DOI: 10.1016/s0264-410x(00)00052-9. View

5.
Read S, Malmstrom V, Powrie F . Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J Exp Med. 2000; 192(2):295-302. PMC: 2193261. DOI: 10.1084/jem.192.2.295. View